» Articles » PMID: 18161917

JAK-STAT Pathway in Carcinogenesis: is It Relevant to Cholangiocarcinoma Progression?

Overview
Specialty Gastroenterology
Date 2007 Dec 29
PMID 18161917
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The features of JAK-STAT signaling in liver cells are discussed in the current review. The role of this signaling cascade in carcinogenesis is accentuated. The possible involvement of this pathway and alteration of its elements are compared for normal cholangiocytes, cholangiocarcinoma predisposition and development. Prolactin and interleukin-6 are described in detail as the best studied examples. In addition, the non-classical nuclear translocation of cytokine receptors is discussed in terms of its possible implication to cholangiocarcinoma development.

Citing Articles

Adjuvant Properties of Caffeic Acid in Cancer Treatment.

Cortez N, Villegas C, Burgos V, Cabrera-Pardo J, Ortiz L, Gonzalez-Chavarria I Int J Mol Sci. 2024; 25(14).

PMID: 39062873 PMC: 11276737. DOI: 10.3390/ijms25147631.


Cuproptosis-related genes score and its hub gene GCSH: A novel predictor for cholangiocarcinomas prognosis based on RNA seq and experimental analyses.

He R, Li Y, Jiao P, Huang Y, Dong S, Mo L J Cancer. 2024; 15(6):1551-1567.

PMID: 38370386 PMC: 10869970. DOI: 10.7150/jca.92327.


Role of JAK2/STAT3 Signaling Pathway in the Tumorigenesis, Chemotherapy Resistance, and Treatment of Solid Tumors: A Systemic Review.

Ayele T, Muche Z, Teklemariam A, Kassie A, Abebe E J Inflamm Res. 2022; 15:1349-1364.

PMID: 35241923 PMC: 8887966. DOI: 10.2147/JIR.S353489.


Simvastatin impairs growth hormone-activated signal transducer and activator of transcription (STAT) signaling pathway in UMR-106 osteosarcoma cells.

Sandoval-Usme M, Umana-Perez A, Guerra B, Hernandez-Perera O, Hernandez-Perera O, Garcia-Castellano J PLoS One. 2014; 9(1):e87769.

PMID: 24489959 PMC: 3906206. DOI: 10.1371/journal.pone.0087769.


Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinoma.

Zhai B, Sun X World J Hepatol. 2013; 5(7):345-52.

PMID: 23898367 PMC: 3724962. DOI: 10.4254/wjh.v5.i7.345.


References
1.
Hayakawa F, Naoe T . SFK-STAT pathway: an alternative and important way to malignancies. Ann N Y Acad Sci. 2006; 1086:213-22. DOI: 10.1196/annals.1377.002. View

2.
Perrais M, Pigny P, Ducourouble M, Petitprez D, Porchet N, Aubert J . Characterization of human mucin gene MUC4 promoter: importance of growth factors and proinflammatory cytokines for its regulation in pancreatic cancer cells. J Biol Chem. 2001; 276(33):30923-33. DOI: 10.1074/jbc.M104204200. View

3.
Cao J, Wood M, Liu Y, Hoffman T, Hyde J, Park-Sarge O . Estradiol represses prolactin-induced expression of Na+/taurocholate cotransporting polypeptide in liver cells through estrogen receptor-alpha and signal transducers and activators of transcription 5a. Endocrinology. 2003; 145(4):1739-49. DOI: 10.1210/en.2003-0752. View

4.
Bjornstrom L, Kilic E, Norman M, Parker M, Sjoberg M . Cross-talk between Stat5b and estrogen receptor-alpha and -beta in mammary epithelial cells. J Mol Endocrinol. 2001; 27(1):93-106. DOI: 10.1677/jme.0.0270093. View

5.
Mertani H, Raccurt M, Abbate A, Kindblom J, Tornell J, Billestrup N . Nuclear translocation and retention of growth hormone. Endocrinology. 2003; 144(7):3182-95. DOI: 10.1210/en.2002-221121. View